Tango Therapeutics (TNGX) News Today → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free TNGX Stock Alerts $7.60 +0.29 (+3.97%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 1:14 AM | americanbankingnews.comQ2 2024 Earnings Forecast for Tango Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:TNGX)May 13 at 1:14 AM | americanbankingnews.comQ2 2024 EPS Estimates for Tango Therapeutics, Inc. (NASDAQ:TNGX) Decreased by WedbushMay 12 at 3:57 AM | americanbankingnews.comHC Wainwright Reaffirms Buy Rating for Tango Therapeutics (NASDAQ:TNGX)May 10, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Trading Down 7.3%Tango Therapeutics (NASDAQ:TNGX) Shares Down 7.3%May 10, 2024 | marketbeat.comFisher Asset Management LLC Takes Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)Fisher Asset Management LLC purchased a new stake in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 100,691 shares of the company's stock, valued at approximMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Tango Therapeutics on Promising PRMT5 Inhibitors and Strong FinancialsMay 9, 2024 | marketbeat.comTango Therapeutics' (TNGX) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $17.00 price target on shares of Tango Therapeutics in a research report on Thursday.May 8, 2024 | investorplace.comTNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | businesswire.comTango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business HighlightsMay 5, 2024 | americanbankingnews.comMva Investors, Llc Sells 60,000 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) StockMay 5, 2024 | americanbankingnews.comMva Investors, Llc Sells 75,000 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) StockMay 4, 2024 | insidertrades.comInsider Selling: Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells 60,000 Shares of StockMay 3, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells $456,600.00 in StockTango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Mva Investors, Llc sold 60,000 shares of Tango Therapeutics stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $7.61, for a total transaction of $456,600.00. Following the sale, the insider now owns 483,524 shares in the company, valued at approximately $3,679,617.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.April 25, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Down 7%Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 7%April 19, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Down 3.8%Tango Therapeutics (NASDAQ:TNGX) Shares Down 3.8%April 18, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Expected to Post Q2 2024 Earnings of ($0.34) Per ShareTango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Investment analysts at B. Riley issued their Q2 2024 earnings per share (EPS) estimates for shares of Tango Therapeutics in a report issued on Monday, April 15th. B. Riley analyst Y. Zhi expects that the company will earn ($0.34) per share foApril 17, 2024 | marketbeat.comTango Therapeutics, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.33) Per Share (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Investment analysts at B. Riley issued their Q1 2024 earnings estimates for Tango Therapeutics in a report issued on Monday, April 15th. B. Riley analyst Y. Zhi forecasts that the company will post earnings of ($0.33) per share for the quarteApril 12, 2024 | marketbeat.comFY2024 Earnings Estimate for Tango Therapeutics, Inc. Issued By Cantor Fitzgerald (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Cantor Fitzgerald issued their FY2024 earnings per share estimates for Tango Therapeutics in a research note issued on Tuesday, April 9th. Cantor Fitzgerald analyst E. Schmidt expects that the company will post earnings of ($1.28) per share fApril 12, 2024 | marketbeat.comVanguard Group Inc. Purchases 197,624 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX)Vanguard Group Inc. lifted its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 7.2% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,939,843 shares of the company's stock after acquiring an additional 197,624 shares during tApril 5, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Down 3.3% Tango Therapeutics (NASDAQ:TNGX) Trading Down 3.3%April 4, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Up 5.2%Tango Therapeutics (NASDAQ:TNGX) Trading Up 5.2%April 4, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Earns Overweight Rating from Analysts at Cantor FitzgeraldCantor Fitzgerald initiated coverage on Tango Therapeutics in a research note on Thursday. They issued an "overweight" rating for the company.April 1, 2024 | businesswire.comTango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 21, 2024 | markets.businessinsider.comBuy Rating Affirmed for Tango Therapeutics on Strong Pipeline and Financial StabilityMarch 21, 2024 | marketbeat.comQ1 2024 Earnings Forecast for Tango Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Equities research analysts at Leerink Partnrs decreased their Q1 2024 earnings estimates for shares of Tango Therapeutics in a research note issued on Monday, March 18th. Leerink Partnrs analyst A. Berens now forecasts that the company will pMarch 20, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Up After Analyst UpgradeTango Therapeutics (NASDAQ:TNGX) Shares Gap Up Following Analyst UpgradeMarch 20, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) PT Raised to $17.00 at HC WainwrightHC Wainwright boosted their target price on Tango Therapeutics from $16.00 to $17.00 and gave the company a "buy" rating in a research report on Wednesday.March 20, 2024 | finance.yahoo.comTango Therapeutics Inc (TNGX) Reports Full Year and Q4 2023 Financial ResultsMarch 18, 2024 | marketbeat.comWedbush Reaffirms "Outperform" Rating for Tango Therapeutics (NASDAQ:TNGX)Wedbush reiterated an "outperform" rating and issued a $18.00 target price on shares of Tango Therapeutics in a research note on Monday.March 18, 2024 | investorplace.comTNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023March 18, 2024 | benzinga.comRecap: Tango Therapeutics Q4 EarningsMarch 18, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Down to $9.03Tango Therapeutics (NASDAQ:TNGX) Shares Gap Down to $9.03March 12, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Down 6% Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 6%March 11, 2024 | finance.yahoo.comTNGX Aug 2024 20.000 putMarch 9, 2024 | marketbeat.comInvesco Ltd. Has $8.72 Million Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)Invesco Ltd. increased its position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 3,247.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 774,738 shares of the company's stock after purchaMarch 8, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Increases Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)Adage Capital Partners GP L.L.C. boosted its stake in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 47.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,754,852 shares ofMarch 8, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Boosts Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)Adage Capital Partners GP L.L.C. raised its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 47.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,754,852 shares of the company's stock after purchasMarch 6, 2024 | businesswire.comTango Therapeutics to Participate in Upcoming Investor ConferencesMarch 6, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 205.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 367,357 shares of the company's stock after purchasing aMarch 5, 2024 | globenewswire.comTango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024March 3, 2024 | finance.yahoo.comCompanies Like Tango Therapeutics (NASDAQ:TNGX) Are In A Position To Invest In GrowthFebruary 26, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Shares Purchased by Fmr LLCFmr LLC raised its holdings in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 12.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,645,741 shares of the company's stock after purchasiFebruary 25, 2024 | marketbeat.comDekaBank Deutsche Girozentrale Takes Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)DekaBank Deutsche Girozentrale bought a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 60,000 shares of the company's stock, valued at approximately $653,000. DekaBank Deutsche GirozenFebruary 17, 2024 | finance.yahoo.comTNGX Mar 2024 7.500 callFebruary 17, 2024 | finance.yahoo.comTNGX Mar 2024 12.500 callFebruary 12, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Up to $12.41Tango Therapeutics (NASDAQ:TNGX) Shares Gap Up to $12.41February 7, 2024 | marketbeat.comTango Therapeutics, Inc. to Post Q1 2024 Earnings of ($0.30) Per Share, Leerink Partnrs Forecasts (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2024 earnings per share estimates for shares of Tango Therapeutics in a report released on Monday, February 5th. Leerink Partnrs analyst A. Berens anticipates that the company willJanuary 31, 2024 | finance.yahoo.comTango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceJanuary 7, 2024 | seekingalpha.comTango Therapeutics Must Produce Its Own Data To Justify Its ValuationJanuary 4, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Tango Therapeutics (TNGX), Esperion (ESPR) Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Truth about Trump you’ve never heard (Ad)Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. TNGX Media Mentions By Week TNGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNGX News Sentiment▼-0.190.56▲Average Medical News Sentiment TNGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNGX Articles This Week▼182▲TNGX Articles Average Week Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EOLS News Today PLRX News Today ZNTL News Today ALXO News Today LBPH News Today ETNB News Today SAGE News Today PRAX News Today OPK News Today ARQT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNGX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Crypto 9-5 Escape PlanCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
